Northwire Canada EditionWednesday, July 29, 2026
Northwire
CYG 0.140 +0.0% IZN 0.060 +0.0% XXIX 0.110 +0.0% MERG 0.850 +0.0% LEGY 0.890 +1.1% GTWO 9.17 −3.8% CDA 0.900 +1.1% AUMB 0.565 −2.6% BOL 0.075 +15.4% ABRA 13.57 −5.8% GMIN 40.26 −4.4% PBM 0.045 +0.0% AEF 0.145 +0.0% EDCU 0.400 −12.1% SCD 0.165 −2.9% DLTA 0.155 +0.0% CYG 0.140 +0.0% IZN 0.060 +0.0% XXIX 0.110 +0.0% MERG 0.850 +0.0% LEGY 0.890 +1.1% GTWO 9.17 −3.8% CDA 0.900 +1.1% AUMB 0.565 −2.6% BOL 0.075 +15.4% ABRA 13.57 −5.8% GMIN 40.26 −4.4% PBM 0.045 +0.0% AEF 0.145 +0.0% EDCU 0.400 −12.1% SCD 0.165 −2.9% DLTA 0.155 +0.0%
Other

Medbright AI talks up investment in Algo8

GOGO · Price

Executive Summary

  • Medbright AI Investments Inc. provided a strategic update on its $900,000 cornerstone investment in Algo8 Industrial AI Inc., made in March 2025, highlighting Algo8's progress in expanding its technological capabilities and market presence.
  • The update details the deployment of Algo8’s "PlantBrain" platform, which utilizes AI digital twins for real-time plant monitoring and predictive maintenance, aiming to drive efficiency and sustainability in industrial environments.
  • Medbright AI announced the grant of 2,000,000 Restricted Share Units (RSUs) to Director Brandon Kou, vesting immediately, subject to a statutory hold period.

Key Details

  • Investment Context: Medbright AI made an initial $900,000 investment in Algo8 Industrial AI Inc. in March 2025 to participate in the high-growth industrial AI sector.
  • Technological Progress: Algo8 has leveraged the capital to advance its core AI technologies, specifically the PlantBrain platform.
  • Platform Capabilities: PlantBrain uses AI digital twins for real-time plant monitoring and predictive maintenance to optimize industrial operations.
  • Strategic Goals: The investment aims to accelerate Algo8's development of next-generation AI solutions for efficiency, sustainability, and automation in industrial environments.
  • Executive Compensation: 2,000,000 RSUs were granted to Brandon Kou, Director of Medbright AI.
  • Vesting Terms: The RSUs vest immediately.
  • Hold Period: The securities are subject to a statutory hold period of four months plus one day from the date of issuance.

Notable Quotes

  • Brandon Kou, Director, Medbright AI: "We are incredibly pleased with the progress Algo8 has made since our investment... Their ability to rapidly deploy advanced solutions that directly address the need for smarter, more efficient and sustainable factories validates our strategic vision."
  • Nandan Mishra, CEO, Algo8: "The strategic investment from Medbright AI has been instrumental in allowing us to accelerate our product road map and expand our reach into new markets... We have made significant strides in advancing our AI-driven solutions for clients, helping them achieve tangible results in terms of operational efficiency and cost savings."
Read the original news release →

More from Medbright AI Investments Inc